Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Guner Hayri Özsan"'
Autor:
Nurhilal Büyükkurt, Guner Hayri Özsan, Sermin Özkal, Gülşah Seydaoğlu, İnci Alacacıoğlu, Mehmet Ali Özcan, Fatih Demirkan, Özden Pişkin, Bülent Ündar
Publikováno v:
Cukurova Medical Journal, Vol 42, Iss 3, Pp 499-506 (2017)
Amaç: Birçok faktör hematopoetik kök hücre (HKH) engraftmanını etkiler. Bu çalışmada hematolojik kanseri olan hastalarda kemik iliğindeki myelofibrozis ve anjiogenezisin engraftman üzerine etkisi araştırılmıştır.Gereç ve Yöntem: O
Externí odkaz:
https://doaj.org/article/469bcc27f93e431aafcbf932258c804b
Autor:
Meral Beksac, Tulin Tuglular, Francesca Gay, Roberto Mina, Eirini Katodritou, Ali Unal, Michele Cavo, Guner Hayri Ozsan, Vincent H.J. van der Velden, Berna Beverloo, Michael Vermeulen, Mark van Duin, Guldane Cengiz, Omur Gokmen Sevindik, Serena Merante, Kyriaki Manousou, Pieter Sonneveld, Evangelos Terpos
Publikováno v:
HemaSphere, Vol 7, p e994593a (2023)
Externí odkaz:
https://doaj.org/article/a44f78ab5cda47d5a5a3846c78a3309a
Autor:
Özgür Mehtap, Tayfur Toptas, Mehmet Sinan Dal, Güner Hayri Özsan, Nigün Sayinalp, Güray Saydam, Mehmet Ali Uçar, Hakki Onur Kirgizlar, Ozan Salim, Atakan Tekinalp, Fahir Özkalemkaş, Funda Pepedil Tanrikulu, Olga Meltem Akay, Emrah Kiliçaslan, Semra Paydas, Sinem Civriz, Mehmet Yilmaz, Volkan Karakuş, Fatma Geçgel, Tahir Darçin, Elçin Erdoğan, Erkin Çinar, Fatma Keklik Karadağ, Ünal Ataş, Vildan Gürsoy, Salih Sertaç Durusoy, Elif Birtaş Ateşoğlu, Anil Tombak, Nurhilal Büyükkurt, Muhit Özcan, Fevzi Altuntaş, Ahmet Burhan Ferhanoğlu
Publikováno v:
HemaSphere, Vol 7, p e566791c (2023)
Externí odkaz:
https://doaj.org/article/e9b3c75689fe4673b443fbabb3a75f21
Autor:
Ahmet Seyhanlı, Boran Yavuz, Zehra Akşit, Zeynep Yüce, Sermin Özkal, Oğuz Altungöz, Fatih Demirkan, İnci Alacacıoğlu, Güner Hayri Özsan
Publikováno v:
Turkish Journal of Hematology, Vol 39, Iss 2, Pp 109-116 (2022)
Objective: Multiple myeloma (MM) is a malignant condition characterized by the accumulation of malignant plasma cells. Although MM remains incurable, the survival of MM patients has improved considerably due to the application of autologous stem cell
Externí odkaz:
https://doaj.org/article/a9f9a3e8d1444c2c9d9e8ff29832771c
Autor:
Sinem Civriz Bozdağ, Güldane Cengiz Seval, İpek Yönal Hindilerden, Fehmi Hindilerden, Neslihan Andıç, Mustafa Baydar, Lale Aydın Kaynar, Selami Koçak Toprak, Hasan Sami Göksoy, Berrin Balık Aydın, Ufuk Demirci, Ferda Can, Vildan Özkocaman, Eren Gündüz, Zeynep Tuğba Güven, Zübeyde Nur Özkurt, Sinan Demircioğlu, Meral Beksaç, İdris İnce, Umut Yılmaz, Hilal Eroğlu Küçükdiler, Elgün Abishov, Boran Yavuz, Ünal Ataş, Yaşa Gül Mutlu, Volkan Baş, Fahir Özkalemkaş, Hava Üsküdar Teke, Vildan Gürsoy, Serhat Çelik, Rafiye Çiftçiler, Münci Yağcı, Pervin Topçuoğlu, Özcan Çeneli, Hamza Abbasov, Cem Selim, Muhlis Cem Ar, Orhan Kemal Yücel, Sevil Sadri, Canan Albayrak, Ahmet Muzaffer Demir, Nil Güler, Muzaffer Keklik, Hatice Terzi, Ali Doğan, Zeynep Arzu Yegin, Meltem Kurt Yüksel, Soğol Sadri, İrfan Yavaşoğlu, Hüseyin Saffet Beköz, Tekin Aksu, Senem Maral, Veysel Erol, Leylagül Kaynar, Osman İlhan, Ali Zahit Bolaman, Ömür Gökmen Sevindik, Arzu Akyay, Muhit Özcan, Günhan Gürman, Şule Ünal, Yasemin Yavuz, Reyhan Diz Küçükkaya, Güner Hayri Özsan
Publikováno v:
Turkish Journal of Hematology, Vol 39, Iss 1, Pp 43-54 (2022)
Objective: Patients with solid malignancies are more vulnerable to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection than the healthy population. The outcome of SARS-CoV-2 infection in highly immunosuppressed populations, such as
Externí odkaz:
https://doaj.org/article/ef03a300a9a44beba39b3be598d50f71
Autor:
Serife Solmaz, Celal Acar, Ahmet Seyhanlı, Omur Gokmen Sevindik, Ozden Piskin, Mehmet Ali Ozcan, Fatih Demirkan, Bülent Undar, Inci Alacacioglu, Guner Hayri Ozsan
Publikováno v:
Indian Journal of Transplantation, Vol 14, Iss 1, Pp 57-62 (2020)
Introduction: High-dose chemotherapy (HDC) and autologous stem cell transplantation(ASCT) still remains in the treatment of myeloma patients even during the period of new agents. Materials and Methods: We analysed the prognostic affect of pretranspla
Externí odkaz:
https://doaj.org/article/d3fc096c721d4ec1a3550a2022a31539
Autor:
Süleyman Cem Adıyaman, İnci Alacacıoğlu, Ayça Ersen Danyeli, Doğuş Türkyılmaz, Ömür Gökmen Sevindik, Fatih Demirkan, Özden Pişkin, Mehmet Ali Özcan, Bülent Ündar, Şermin Özkal, Güner Hayri Özsan
Publikováno v:
Turkish Journal of Hematology, Vol 36, Iss 2, Pp 81-87 (2019)
Objective: Diffuse large B-cell lymphoma (DLBCL) is the most common type of non-Hodgkin lymphoma (NHL). The treatment of older NHL patients has always been a struggle; however, treatment statistics have begun showing favorable results similar to thos
Externí odkaz:
https://doaj.org/article/a052bd3670754c85b2d726bbebae4be3
Autor:
Seda Baykal-Köse, Eda Acikgoz, Ahmet Sinan Yavuz, Öykü Gönül Geyik, Halil Ateş, Osman Uğur Sezerman, Güner Hayri Özsan, Zeynep Yüce
Publikováno v:
PLoS ONE, Vol 15, Iss 2, p e0229104 (2020)
Tyrosine kinase inhibitor (TKI) resistance is a major problem in chronic myeloid leukemia (CML). We generated a TKI-resistant K562 sub-population, K562-IR, under selective imatinib-mesylate pressure. K562-IR cells are CD34-/CD38-, BCR-Abl-independent
Externí odkaz:
https://doaj.org/article/71f26500ab274936836a6f12a40bb100
Autor:
Şerife Solmaz Medeni, Doğus Türkyılmaz, Celal Acar, Ömür Gökmen Sevindik, Faize Yüksel, Özden Pişkin, Mehmet Ali Özcan, Fatih Demirkan, Bülent Ündar, İnci Alacacıoğlu, Güner Hayri Özsan
Publikováno v:
Turkish Journal of Hematology, Vol 35, Iss 4, Pp 271-276 (2018)
Objective: High-doses of melphalan treatment with autologous stem cell transplantation in multiple myeloma (MM) remains a major treatment modality in suitable patients. A minimal dose of 2x106/kg CD34+ cells is preferred to achieve engraftment. Some
Externí odkaz:
https://doaj.org/article/3903f33454c340b9bbc990d2d2e4c0d0
Autor:
Ömür Gökmen Sevindik, İnci Alacacıoğlu, Abdullah Katgı, Şerife Medeni Solmaz, Celal Acar, Özden Pişkin, Mehmet Ali Özcan, Fatih Demirkan, Bülent Ündar, Güner Hayri Özsan
Publikováno v:
Case Reports in Hematology, Vol 2015 (2015)
Transplantation-associated thrombotic microangiopathy (TA-TMA) is a challenge after allogeneic hematopoietic progenitor cell transplantation, considering the diagnostic uncertainties and lack of established treatment. We report a 43-year-old male pat
Externí odkaz:
https://doaj.org/article/6097feba29e24b9cae7ac56646388297